Chemical Compound
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(2-triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate; N-2 Trityl Olmesartan Medoxomil
CAS Registry Number
1020157-01-0
Primary record
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(2-triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate; N-2 Trityl Olmesartan Medoxomil
- 库存
- 9,676 克
- 纯度
- 98.1 %
- CAS
- 1020157-01-0
化合物标识与属性
- CAS
- 1020157-01-0
- PubChem CID
- 10700531
- SMILES
- CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN(N=N4)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC8=C(OC(=O)O8)C)C(C)(C)O
- Canonical SMILES
- CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)cc1
名称与同义词
- N2-Tritylolmesartan medoxomil
- N2-Trityl olmesartan medoxomil
- Trityl Olmesartan Medoxomil
- N-2 Trityl Olmesartan Medoxomil
- Olmesartan impurity D
- UNII-KIU4Z454AM
- 1020157-01-0
- Olmesartan EP impurity D
- KIU4Z454AM
- RefChem:202236
- SCHEMBL94332
- Olmesartan Medoxomil EP Impurity D
- N-2Trityl olmesartan medoxomil
- Olmesartan medoxomil impurity D
- Olmesartan medoxomil impurity D [EP]
- C48H44N6O6
- CS-T-62583
- CID10700531
- CID 10700531
- IH139102
- OLMESARTAN MEDOXOMIL IMPURITY D [EP IMPURITY]
- A898851
- OLMESARTAN MEDOXOMIL IMPURITY D (EP IMPURITY)
- Q27282272
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-((2-triphenylmethyl)-2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(2-(triphenylmethyl)-2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(2-trityl-2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(2-triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate; N-2 Trityl Olmesartan Medoxomil
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-(5-methyl-2-oxo-1,3-d ioxol-4-yl)1H-Imidazole-5-carboxylic acid methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo -1,3-dioxol-4-yl)methyl Ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[2'-(2-trityl-2H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxole-4-yl)methyl ester
- 5-(1-Hydroxy-1-methyl-ethyl)-2-propyl-3-[2'-(2-trityl-2H-tetrazol-5-yl)-bipheny l-4-ylmethyl]-3H-imidazole-4-carboxylic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester
- N2-Trityl Olmesartan Medoxomil; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate